NewGenIvf Group Limited (NIVF)

NASDAQ: NIVF · USD

$0.85

-0.08 (-8.1%)· Recorded snapshot

Market cap	8.4M
Revenue (ttm)	4.6M
Net income (ttm)	1.1M
Shares out	9.9M
P/E (trailing)	7.5x
P/E (forward)	0.0x
Volume	163,745.433
Beta	0.06

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.6M
Net income (ttm): 1.1M
P/E (trailing): 7.5x
P/E (forward): 0.0x
Market cap: 8.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/E0

P25 13.4P50 20.2P75 35.7

Trailing P/E7.5

P25 15.4P50 25.8P75 43.5

ROE5.5

P25 -113.8P50 -46.5P75 -0.9

ROIC-50.5

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All NIVF indicators

Market & fundamental data

Available fields

196

Groups with data

Currency

USD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001981662
Company name	NewGenIvf Group Limited
Country	Thailand
Country code	US
CUSIP number	G0544E501
Earnings date	2026-11-20
Employees	87
Employees change	11
Employees growth	14.47%
Enterprise value	$5.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
Industry	Medical Care Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	VGG0544E1622
Last 10-K release date	2026-03-31
Last earnings date	2026-09-01
Last refreshed	2026-11-04
Last stock split date	2026-10-23
Last stock split type	Reverse
Market cap	$8.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-20
Options	No
Price	$0.85
Price currency	USD
Sector	Healthcare
SIC code	8090
Stock price date	2026-11-03
Symbol	NIVF
Website	https://www.nivf.global

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	421.33x
Earnings yield	13.31%
EV/Earnings	5.03x
EV/Sales	1.22x
FCF / EV yield	-263.28%
FCF yield	-176.22%
Forward P/E	0x
Industry forward P/E	15.46x
Industry P/E	17.9x
P/B ratio	0x
P/E ratio	7.51x
P/S ratio	1.82x
Price / tangible book value	1.68x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-238.22%
EBITDA margin	-230.81%
Gross margin	23.89%
Operating margin	-238.22%
Pretax margin	20.54%
Profit margin	24.16%
Profit per employee	$12,864
Profitable years	1
Revenue per employee	$53,238
ROA	-26.91%
ROCE	-42.55%
ROE	5.51%
ROIC	-50.49%
SBC / revenue	1.16%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	-26.32%
Gross profit growth (Q)	48.02%
Gross profit growth 3Y	0.81%
Net income growth	87.5%
Net income growth years	1
Revenue growth	-2.82%
Revenue growth (Q)	-4.69%
Revenue growth (QoQ)	0%
Revenue growth 3Y	0.66%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-181,842
Depreciation and amortization	$272,413
EBIT	$-11M
EBITDA	$-10.7M
FCF per share	$-1.50
Financing cash flow	$14.1M
Free cash flow	$-14.8M
Gross profit	$1.1M
Investing cash flow	$-72,347
Net cash flow	$-584,687
Net income	$1.1M
Operating cash flow minus SBC	$-14.7M
Operating income	$-11M
Revenue	$4.6M
Stock-based compensation	$53,583

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.71
Book value per share	$733.75
Debt / equity	0.06
Interest coverage	-10.69
Long-term assets	$25.3M
Long-term liabilities	$215,087
Net cash (debt)	$2.8M
Net cash / market cap	33.07%
Net debt / equity	-0.11
Piotroski F-Score	1
Property, plant and equipment	$2.2M
Shareholders' equity	$25.7M
Tangible book value	$5M
Tangible book value per share	$139.18
Total assets	$36.4M
Total cash	$4.4M
Total debt	$1.6M
Total liabilities	$10.7M
WACC	11.92%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.18
Current assets	$11.1M
Current liabilities	$10.5M
Current ratio	1.06
Inventory turnover	15.76
Net working capital	$-2.4M
Quick ratio	0.55
Working capital	$618,325
Working capital turnover	2.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$181.89
1D price change	-8.13%
1M price change	-79.41%
1M total return	-79.41%
1W price change	-26.09%
1W total return	-26.09%
1Y price change	-99.99%
1Y return CAGR	-99.99%
1Y total return	-99.99%
20-day SMA	$1.71
200-day SMA	$378.01
3M price change	-98.91%
3M total return	-98.91%
3Y price change	-100%
3Y return CAGR	-99.83%
3Y total return	-100%
50-day SMA	$16.41
50-day SMA vs 200-day SMA	50under200
52-week high	$20,908.79
52-week high date	2025-11-03
52-week low	$0.83
52-week low date	2026-11-03
6M price change	-99.83%
6M total return	-99.83%
After-hours change	-2.35%
After-hours close	$0.85
After-hours price	$0.83
All-time high	$297,754,749.57
All-time high date	2024-03-08
All-time low	$0.83
All-time low date	2026-11-03
Average true range (ATR)	$1.44
Average volume	2.2M
Beta (1Y)	3.03
Beta (2Y)	2.49
Beta (5Y)	0.06
Change from 52-week high	-100%
Change from 52-week low	2.41%
Change from all-time high	-100%
Change from all-time low	2.41%
Change from open	-5.56%
Day's gap	-2.72%
Dollar volume	$139,184
High price	$0.91
Low price	$0.83
Monthly RSI	8.34
Open price	$0.90
Position in 52-week range	24.91%
Premarket change	-3.53%
Premarket close	$0.85
Premarket price	$0.82
Premarket volume	11.3K
Previous close	$0.93
Price vs 150-day SMA	-99.53%
Price vs 20-day SMA	-50.23%
Price vs 200-day SMA	-99.78%
Price vs 50-day SMA	-94.82%
Relative volume	0.07
RSI	22.27
Sharpe ratio	-2.85
Sharpe ratio (3Y)	-1.74
Sortino ratio	-4.08
Sortino ratio (3Y)	-2.78
Volume	163.7K
Weekly RSI	24.68
YTD price change	-99.96%
YTD total return	-99.96%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9.8M
Float percentage	98.87%
Shares held by insiders	0.48%
Shares held by institutions	0.01%
Shares outstanding	9.9M
Short % of float	25.25%
Short % of shares	24.97%
Short ratio	0.1 days

Deeper analysis on NIVF

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NIVF report

Is a complete NIVF research report available?

No complete published report is available for NewGenIvf Group Limited (NIVF) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NewGenIvf Group Limited (NIVF)

Price

Financial snapshot

Fair-value bridge

Latest news · NIVF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NIVF indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NIVF

Frequently asked questions